LEUPROLIDE ACETATE and ASTHENIA

Overview

ASTHENIA is the #10 most commonly reported adverse reaction for LEUPROLIDE ACETATE, manufactured by TOLMAR Inc.. There are 2,351 FDA adverse event reports linking LEUPROLIDE ACETATE to ASTHENIA. This represents approximately 1.8% of all 133,873 adverse event reports for this drug.

Patients taking LEUPROLIDE ACETATE who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ASTHENIA2,351 of 133,873 reports

ASTHENIA is a less commonly reported adverse event for LEUPROLIDE ACETATE, but still significant enough to appear in the safety profile.

Other Side Effects of LEUPROLIDE ACETATE

In addition to asthenia, the following adverse reactions have been reported for LEUPROLIDE ACETATE:

HOT FLUSH — 9,491 reports
INTERCEPTED PRODUCT PREPARATION ERROR — 8,862 reports
DEATH — 8,129 reports
SYRINGE ISSUE — 7,867 reports
DEVICE LEAKAGE — 6,008 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS — 5,218 reports
FATIGUE — 5,009 reports
INJECTION SITE PAIN — 4,833 reports
PROSTATIC SPECIFIC ANTIGEN INCREASED — 2,395 reports
DRUG INEFFECTIVE — 2,248 reports

Other Drugs Associated with ASTHENIA

The following drugs have also been linked to asthenia in FDA adverse event reports:

0XYGEN ABEMACICLIB ABIRATERONE ACETATE ACALABRUTINIB ACETAMINOPHEN ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN TABLET EXTENDED RELEASE ACYCLOVIR ADO TRASTUZUMAB EMTANSINE

Does LEUPROLIDE ACETATE cause ASTHENIA?

ASTHENIA has been reported as an adverse event in 2,351 FDA reports for LEUPROLIDE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ASTHENIA with LEUPROLIDE ACETATE?

ASTHENIA accounts for approximately 1.8% of all adverse event reports for LEUPROLIDE ACETATE, making it a notable side effect.

What should I do if I experience ASTHENIA while taking LEUPROLIDE ACETATE?

If you experience asthenia while taking LEUPROLIDE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.